EMEA dismisses Gardasil risks
This article was originally published in Scrip
Executive Summary
The EU's CHMP has concluded that the serious adverse events suffered by two girls in Spain after vaccination with Sanofi Pasteur MSD's Gardasil (human papillomavirus vaccine) are unlikely to be related to the vaccine. The European Medicines Agency says the benefits of Gardasil continue to outweigh its risks and it recommends that vaccination continue through national programmes.